Failure to Pay for New Molecular CPT Codes Creates Money Crisis for Clinical Laboratories and Pathology Groups
Medicare contractors are setting prices that are 40% to 60% lower than they paid medical laboratories last year for these same molecular diagnostic tests
Non-payment for most new molecular diagnostic test CPT codes continues to be a problem for the majority of medical laboratories across the country.
A lack of payment for these claims, have forced some clinical laboratories and pathology groups to stop doing molecular testing and lay off staff. At least one lab company shut its doors, blaming non-payment by its Medicare contractor as the primary reason.
(more…)